title: Inhibition of in vitro HIV infection by dialysable leucocyte extracts.
abstract: Dialysable Leucocyte Extract (DLE) is a low molecular weight dialysable material of disrupted peripheral human leucocytes with widespread effects on the immune system. We described the in vitro anti-HIV activity of DLE as well as its three chromatographic fractions (Fa, Fb and Fc). To determine the levels of inhibition on HIV replication by DLE we infected MT-4 cell cultures, using the Bru viral isolate at 0.05, 0.1, 0.5 and 1 m.o.i. Previously, MT-4 cells cultures were treated with DLE or fractions at non-toxic concentrations. Reverse transcriptase (RT) activity and p24 antigen were evaluated in culture supernatants at seven days postinfection. No effect was observed when MT-4 cells were incubated with DLE for 3 h. Whereas inhibition of HIV production was observed when MT-4 cells were pre-treated for a longer period of time. DLE inhibited p24 production and RT activity more than 50% at 0.1 m.o.i. More than 80% of inhibition was observed for all doses of DLE tested at 0.05 m.o.i. Higher viral doses (m.o.i. 0.5 and 1) were used to assess the antiviral activity of DLE fractions. Fraction Fb inhibits viral production more than 80%. Otherwise, fractions Fa and Fc did not show inhibitory effect for any viral dose used. These results indicate that DLE is able to modulate cell susceptibility to viral infection in vitro.
authors.affiliation: Department of Cellular Biology, Center for Biological Research and Center for Genetic Engineering and Biotechnology, Havana, Cuba.
authors.forename: C
authors.initials: C
authors.lastname: Fernandez-Ortega
authors.forename: M
authors.initials: M
authors.lastname: Dubed
authors.forename: O
authors.initials: O
authors.lastname: Ruibal
authors.forename: O L
authors.initials: OL
authors.lastname: Vilarrubia
authors.forename: J C
authors.initials: JC
authors.lastname: Menéndez de San Pedro
authors.forename: L
authors.initials: L
authors.lastname: Navea
authors.forename: M
authors.initials: M
authors.lastname: Ojeda
authors.forename: M J
authors.initials: MJ
authors.lastname: Araña
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000821:virology; D002457:Cell Extracts / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003956:Dialysis; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007962:Leukocytes / Q000737:chemistry* / Q000276:immunology*; D014779:Virus Replication / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D002457:Cell Extracts